From the Department of Physiology and Pharmacology (F.B., D.W.B), Bowman
Gray School of Medicine, Wake Forest University, Winston-Salem, NC; the
Department of Physiology (F.B.), Albert Szent-Györgyi Medical University,
Szeged, Hungary; and the Department of Anatomy and Cell Biology (T.M.L.), East
Carolina University, Medical School, Greenville, NC.
Correspondence to David W. Busija, PhD, Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1083. E-mail dbusija{at}bgsm.edu
MethodsPial arteriolar diameters were measured using a cranial
window and intravital microscopy. We examined arteriolar responses to
arterial hypoxia (inhalation of 8.5% and 7.5%
O2), to topical adenosine (105 and
104 mol/L) and to arterial hypercapnia
(inhalation of 5% and 10% CO2 in air) before and after 10
minutes of global ischemia. Ischemia was achieved by
increasing intracranial pressure. Arterial hypercapnia was
used as a positive control for the effectiveness of the
ischemic insult. In addition, we evaluated cerebral arteriolar
responses to 105 and 104 mol/L
adenosine applied topically with or without glibenclamide, a
selective inhibitor of KATP (105
and 106 mol/L). Finally, we administered theophylline (20
mg/kg, IV) to assess the contribution of adenosine to cerebral
arteriolar dilation to arterial hypoxia.
ResultsBefore ischemia, cerebral arterioles dilated by
19±3% to moderate and 29±4% to severe hypoxia (n=7;
P<.05); 13±2% to 105 and 20±1% to
104 mol/L adenosine (n=9; P<.05);
and by 17±2% to moderate and 28±3% to severe hypercapnia (n=6;
P<.05). After ischemia, cerebral arteriolar
responses to hypoxia and adenosine were unchanged. In
contrast, cerebral arteriolar dilation to hypercapnia was impaired by
ischemia (1±1% and 2±1% at 1 hour; n=6). Glibenclamide
reduced cerebral arteriolar dilation to adenosine by
approximately one half (n=7). In addition, blockade of
adenosine receptors by theophylline (20 mg/kg, IV) almost
totally suppressed cerebral arteriolar dilation to arterial
hypoxia (n=6).
ConclusionsCerebrovascular responsiveness is selectively
affected by anoxic stress. In addition, cerebral arteriolar dilation to
hypoxia and adenosine is maintained after
ischemia despite the expected impairment in KATP
function.
In recent studies, we showed that KATP function in
cerebral arterioles is impaired after ischemia. Thus, pial
arteriolar dilations in piglets to aprikalim, CGRP, and iloprost,
pharmacological and physiological
activators of KATP, are largely absent 1 to 2
hours after 10 minutes of total global
ischemia.15 16 In contrast, ischemia fails
to alter cerebrovascular dilation to several stimuli that are not
dependent on activation of KATP.15 17
The purpose of this study was to examine the effects of
ischemia on cerebral arteriolar dilation to
arterial hypoxia in piglets. This is an important
issue because derangements of arterial blood gases and
local ischemia often occur after successful resuscitation of
babies that follows anoxic stress. In addition, we examined the effects
of ischemia on cerebral arteriolar dilation to
adenosine. Topical adenosine allows assessment of
effects of ischemia on a major component of the arteriolar
dilator response to arterial
hypoxia4 7 9 without the presence of other,
possibly complicating features, of hypoxia. We tested the
hypothesis that ischemia-induced reductions in cerebral
arteriolar dilation to arterial hypoxia and
adenosine would be in proportion to dependence of these dilator
responses to KATP. In addition, we also examined the
effects of ischemia on arteriolar dilation to
arterial hypercapnia to validate the potency of the
ischemic stress.18
Cerebral Ischemia-Reperfusion Injury
Experimental Design
Interaction of Ischemia with the Vasodilation to
Adenosine
Contribution of KATP to Adenosine-Evoked
Arteriolar Dilation
Blockade of Adenosine Receptors During Hypoxia
Interaction between Ischemia and Arterial
Hypercapnia
Statistical Analysis
Baseline arteriolar diameters were not different at 1, 2, or 4 hours
after ischemia (Table 1
Adenosine caused dose-dependent pial arteriolar dilation (Table 2
Topical application of glibenclamide in concentrations of
106 or 105 mol/L did not change baseline
pial arteriolar diameters (Table 2
Pial arteriolar dilator responses to hypoxia were reduced after
intravenous administration of theophylline. At 15 minutes
after administration of theophylline, cerebral arteriolar diameters
were not different from baseline values (103±3 versus 101±2
µm). Before theophylline, inhalation of 8.5% O2 resulted
in pial arteriolar dilation of 25±4%. Theophylline administration
resulted in an attenuated cerebral arteriolar dilation to
hypoxia (7±2% above baseline level; P<.05).
Arterial hypercapnia caused repeatable, dose-dependent pial
arteriolar dilation (Table 3
As shown in numerous studies, arterial hypoxia
activates multiple mechanisms that influence cerebrovascular
tone. The relative contribution of various mechanisms of hypoxic
vasorelaxation vary over time and depend on the severity of
hypoxia. There is now a consensus that the release and effects
of adenosine determine the majority of the cerebral vasodilator
response to hypoxia in piglets.4 7 9 For example,
adenosine concentrations in brain interstitial and
cerebrospinal fluids increase to the vasodilator range within the first
minutes of hypoxia.7 9 In addition,
adenosine receptor antagonists4 7 18 23
and adenosine deaminase4 attenuate the hypoxic,
hyperemic response in the cerebral circulation. Our present
results also support the view that adenosine plays a
significant role in hypoxia-induced cerebral vasodilation in
newborn pigs. The relative contribution of adenosine to
hypoxia-induced vascular changes may vary during the postnatal
period24 25 and species-dependent variables may also
exist.10
The mechanism by which endogenous adenosine causes
cerebral vasodilation has been intensively studied.11
Several studies on isolated arteries have shown that adenosine
activates KATP and that this effect was inhibited
by glibenclamide.4 26 27 28 In addition, our data confirm
recent results by Armstead4 and indicate that
KATP contribute to adenosine-induced arteriolar
dilation in the in vivo cerebral circulation of piglets. The
precise mechanism of KATP activation
remains unknown, but probably involves elevation of intracellular cAMP
and stimulation of protein kinase A.27 29
In a previous study, we showed that arteriolar dilator responses to
aprikalim, iloprost, and CGRP, selective activators of
KATP, are greatly reduced after
ischemia.15 16 Aprikalim is a widely used
pharmacological activator of
KATP.22 30 Iloprost, a stable analogue of
prostacyclin, and CGRP may be entirely dependent on activation of
KATP in promoting dilation of cerebral arterioles. Thus,
coadministration of glibenclamide, a selective inhibitor of
KATP, blocked arteriolar dilator responses to all three
substances. In contrast to these three activators of
KATP, adenosine and arterial
hypoxia do not dilate cerebral arterioles exclusively via the
opening of KATP. Thus, approximately one half of the
arteriolar dilation to adenosine4 and
arterial hypoxia4 13 is intact with
coapplication of glibenclamide, which implies that other mechanisms
independent from activation of KATP are also involved.
Nonetheless, based on the relative importance of KATP in
promoting dilation to these stimuli,4 13 it was an
unexpected finding that normal arteriolar responsiveness remained after
ischemia. Our results with adenosine confirm an earlier
report by Mayhan et al.31
We considered several possible explanations to account for the retained
cerebral arteriolar responses to arterial hypoxia
and adenosine. First, alternative dilator mechanisms, including
actions of arachidonic acid19 and other as
yet undefined factors may have compensated for decreased function of
KATP. Although activation of calcium-activated
potassium channels has been shown to participate in dilator responses
of rat isolated cerebral arterioles,32 recent evidence
indicates that their contribution to cerebral arteriolar dilation in
piglets is doubtful.21 Second, the limited KATP
function remaining after ischemia may be sufficient to allow
normal arteriolar responsiveness. In our previous study, modest
arteriolar dilation to aprikalim was present after
ischemia, while glibenclamide coapplication completely
abolished aprikalim-induced dilation.15 Thus, low levels of
KATP function may allow normal arteriolar responsiveness to
be present for arterial hypoxia and
adenosine, perhaps via a "permissive" role as has been
suggested for nitric oxide1 and
prostaglandins.33 34 Third, the effects of
ischemia on arteriolar responses to aprikalim, iloprost, and
CGRP may involve inactivation of sites distinct from the
KATP or of sites that are not essential for channel
functioning.27 For example, ischemia may impair the
function of prostacyclin and CGRP receptors or coupling between
receptors and KATP. In addition, ischemia-induced
alterations in binding sites for aprikalim may not interfere with
adenosine- or hypoxia-stimulated increases in
KATP function. Also, changes in KATP channel
function could be different depending on whether activation is from
extra- or intracellular directions. And fourth, preadministration of
exogenous adenosine or release of endogenous
adenosine by hypoxia could attenuate ischemic
damage11 and thus preserve normal vascular
responsiveness.
In contrast to arterial hypoxia, arteriolar
dilation to arterial hypercapnia was abolished at 1 hour
after ischemia, and normal dilator responses returned to normal
4 hours after ischemia. In piglets, cerebral arteriolar
dilation to arterial hypercapnia is not due to activation
of KATP.19 Recovery of arteriolar
responsiveness to arterial hypercapnia over 2 to 4 hours
after ischemia is similar to those observed previously in
response to aprikalim and iloprost,15 and may
represent general recovery of cerebral blood vessels. It is
interesting that cerebral arteriolar responses to arterial
hypoxia are extremely stable during this period when dilator
responses to other stimuli are attenuated.
Babies are frequently exposed to hypoxic/anoxic stress during the
perinatal period, and cerebrovascular dysfunction may contribute to or
potentiate development of neurological sequelae. Results from the
present study and other studies show that cerebrovascular
responsiveness is affected selectively by anoxic stress. Thus, cerebral
arteriolar dilation to CGRP,16 prostacyclin,15N-methyl-D-aspartate,17 and
arterial hypercapnia is largely abolished by 1 hour after
ischemia, while responsiveness to arterial
hypoxia, adenosine, sodium nitroprusside,17
and prostaglandin E215 is intact.
Proper management of babies after hypoxic/ischemic stress
should take into consideration these relatively selective changes in
responsiveness of the cerebral circulation.
Received June 30, 1997;
revision received September 17, 1997;
accepted October 7, 1997.
Departments
of Physiology, Pharmacology, and Biochemistry and Center
for Perinatal Biology,
Loma Linda University School of Medicine,
Loma Linda, California
To explore a possible mechanistic basis for the selective effects of
cerebral ischemia on different cerebrovascular responses, Bari
et al tested the hypothesis that ischemic attenuation of
hypoxic reactivity reflects the ability of ischemia to inhibit
ATP-sensitive potassium channel function. These channels are clearly
implicated in hypoxic cerebral vasodilatation10 11 12 and
have also been previously shown by the authors to be vulnerable to
ischemia.13 Using ischemic conditions
known to attenuate ATP-sensitive potassium channel function in the
neonatal piglet, the authors found that ischemia also
attenuated hypercapnic reactivity as previously
reported,6 8 14 but had no effect on cerebral
vasodilatation to either hypoxia or adenosine.
Together, these findings reinforce the view that ischemia
selectively alters essential cerebrovascular responses and further
suggest that mechanisms independent of ATP-sensitive potassium channels
can fully mediate postischemic hypoxic cerebral
vasodilatation in the neonate.
Certainly, careful judgment must be exercised when extrapolating
these results to other preparations and situations. The pattern and
distribution of ischemia produced in these studies by
artificially elevating intracranial pressure is quite different from
that produced by vessel occlusion or cardiac arrest. In addition, the
duration of hypoxia tested was relatively brief (3 to 4
minutes) and of moderate intensity
(PaO2
Received June 30, 1997;
revision received September 17, 1997;
accepted October 7, 1997.
© 1998 American Heart Association, Inc.
Original Contributions
Effects of Ischemia on Cerebral Arteriolar Dilation to Arterial Hypoxia in Piglets
![]()
Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Introduction
References
Background and
PurposeArterial hypoxia mediates cerebral
arteriolar dilation primarily via mechanisms involving activation of
ATP-sensitive K+ channels (KATP), which we have
shown to be sensitive to ischemic stress. In this study, we
determined whether ischemia/reperfusion alters cerebral
arteriolar responses to arterial hypoxia in
anesthetized piglets. Since adenosine plays an
important role in cerebrovascular responses to hypoxia, we also
determined whether adenosine-induced arteriolar dilation is
affected by ischemic stress. We tested the hypothesis that
reductions in cerebral arteriolar dilator responses after
ischemia would be proportional to the contribution of
KATP to hypoxia and adenosine.
Key Words: cerebral arteries cerebral circulation vasodilation adenosine calcium channels hypercapnia
![]()
Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Introduction
References
Arterial
hypoxia is a potent dilator stimulus in the cerebral
circulation. Previous studies have provided evidence that
adenosine, nitric oxide, prostanoids, opioids, and/or
vasopressin promote cerebrovascular dilation to arterial
hypoxia.1 2 3 4 5 6 7 8 9 10 11 12 The relative contribution of these
substances to hypoxia-induced cerebrovascular dilation probably
reflects differences in the species studied, the experimental
approaches, and the variability of the severity and duration of hypoxic
challenge.10 However, several lines of evidence indicate
that an elevation of interstitial adenosine
concentration is critical to eliciting hypoxic dilation of pial
arterioles in newborn pigs.4 7 9 Furthermore, activation of
KATP may mediate a substantial part of the cerebrovascular
dilation to arterial hypoxia.4 12 13
This conclusion is based on the finding that application of selective
KATP blockers attenuates cerebral arteriolar dilation to
arterial hypoxia4 13 14 as well as to
adenosine.4 In general, inhibition of
KATP reduces cerebral arteriolar dilation to
arterial hypoxia or adenosine by
approximately 50%.
![]()
Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Introduction
References
Surgical Preparation
Experiments were carried out on newborn pigs (1 to 7 days old)
of either sex weighing 1 to 2 kg. The procedures used in this study
were approved by the Institutional Animal Care and Use Committee. The
piglets were anesthetized with sodium thiopental (30 mg/kg, IP)
and then
-chloralose (75 mg/kg, IV). Additional
-chloralose was
given as needed to maintain a stable level of anesthesia.
The piglets were intubated and artificially ventilated. A femoral
artery and vein were cannulated with PE-90 tubing. Arterial
blood pressure, blood gas values, and pH were maintained within the
normal physiological range. Each piglet's head was
fixed in a stereotaxic apparatus, the scalp was
cut, and the connective tissue over the parietal bone was removed. A
craniectomy (19 mm in diameter) was made in the parietal bone. The
dura was cut and reflected over the skull. A stainless steel and glass
cranial window with three ports was put into the opening, sealed with
bone wax, and cemented with cyanoacrylate ester followed by one or two
layers of dental acrylic. The closed window was filled with aCSF that
was warmed to 37°C and equilibrated with 6% O2, 6.5%
CO2, balance N2. Arterioles were observed using
a microscope (Wild M36) equipped with a television camera (Panasonic),
and arteriolar diameters were measured with a video microscaler
(IV-550, For-A Co).
Cerebral ischemia-reperfusion injury was produced as
described previously.15 17 In brief, a hollow brass bolt
was implanted into the right parietal cranium 20 mm rostral to the
cranial window. Immediately after placement of the cranial window, a
3-mm hole was drilled in the skull using an electric drill with a
toothless bit, and the dura was exposed. A hollow bolt was inserted and
secured in place with cyanoacrylate ester and dental acrylic. After
implantation of the window and the bolt, aCSF was allowed to
equilibrate with the periarachnoid CSF under the window for 20 minutes.
To induce ischemia, aCSF was infused to maintain intracranial
pressure above mean arterial pressure so that blood flow
through pial vessels was stopped. Venous blood was withdrawn as
necessary to maintain mean arterial blood pressure near
normal values. At the end of the 10-minute period of ischemia,
the infusion tube was clamped, and the intracranial pressure was
allowed to return to preischemia values.
Interaction Between Global Ischemia and Arterial
Hypoxia
At the beginning of each experiment, the cranial window was
flushed with aCSF several times. Then, cerebral arteriolar responses
were determined to two levels of arterial hypoxia
(administration of 7.5% and 8.5% O2 in nitrogen). The
exposure to each level of gas was limited to 3 to 4 minutes for two
reasons. First, a 3- to 4-minute period of arterial
hypoxia is sufficient to achieve maximal arteriolar dilation in
piglets, as described by Leffler et al.19 And, second,
repeated exposure to longer periods of arterial
hypoxia might compromise the cerebral circulation when combined
with ischemia. Animals were subsequently divided into either
sham (n=6) or ischemia (n=7) groups. Animals in the sham group
were exposed to two levels of hypoxia 1 hour after the first
exposure. In the ischemia group, after recovery, animals were
exposed to cerebral ischemia for 10 minutes. At 1, 2, and 4
hours after ischemia, cerebral arteriolar responses were again
examined at both levels of arterial hypoxia.
We examined pial arteriolar diameter changes after topical
application of adenosine (at 105 and
104 mol/L). In one group of animals, we determined
whether arteriolar responses to adenosine are reproducible over
time (n=6). Each dose of adenosine in aCSF was introduced into
the window, the infusion was stopped, and pial arteriolar diameters
were recorded over the next 5 to 10 minutes. In a separate group,
cerebral arteriolar responses to topical adenosine (n=9) were
determined before and 1 hour after ischemia.
In two separate groups of animals we monitored the effect of
glibenclamide on adenosine-evoked cerebral arteriolar
responses. We performed these experiments because the contribution of
KATP in mediating adenosine-induced dilation is
controversial.4 13 In one group (n=6), we applied
glibenclamide topically in a concentration of 106 mol/L.
The concentration of glibenclamide was 105 mol/L in the
other group. These doses selectively inhibit KATP
function.13 14 15 16 Glibenclamide was dissolved in dimethyl
sulfoxide. The concentration of dimethyl sulfoxide was less than 0.1%,
which is below the vasoactive range. Glibenclamide was applied
topically 5 minutes before the adenosine administration. Then,
the two drugs were applied together. We13 14 15 16 and
others21 22 have shown previously that these doses of
glibenclamide given in this way are effective and specific in blocking
cerebral arteriolar dilation to aprikalim, a selective
activator of KATP.
We determined cerebral arteriolar dilator responses during
arterial hypoxia before and 15 minutes after
intravenous administration of theophylline (20 mg/kg)
(n=6). We did these experiments because the contribution of
adenosine to cerebral arteriolar dilation in piglets is
controversial.19 To document effectiveness of blockade, we
also determined dilator responses to topical adenosine
(105 and 104 mol/L) before and after
administration of theophylline (n=4).
As a positive control, effects of ischemia on arteriolar
responses to arterial hypercapnia were examined. In the
ischemia group (n=6), pial arteriolar responses to
arterial hypercapnia (5% and 10% CO2 in air)
were examined before and 1, 2, and 4 hours after ischemia.
Piglets were exposed to each level of gas for at least 10 minutes. In
the sham group (n=4), the hypercapnic challenge was repeated at 1, 2,
and 4 hours after the first hypercapnic episodes.
All values are expressed as mean± SEM. When appropriate, data
were analyzed using the paired t test or repeated
measures ANOVA, or one way ANOVA. When the F value was significant,
pair-wise comparisons were made using the Student-Newman-Keuls test. A
value of P<.05 was considered statistically
significant.
![]()
Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Introduction
References
Arterial hypoxia dilated pial arterioles in a
dose-dependent fashion (Table 1
; Fig 1
). Repeated hypoxia resulted in
reproducible cerebral arteriolar dilation over time without altering
baseline diameters (Table 1
).
View this table:
[in a new window]
Table 1. Arteriolar Responses to Hypoxia

View larger version (26K):
[in a new window]
Figure 1. Percent change from control arteriolar diameter
during two different levels of hypoxic hypoxia (inhalation of
8.5% or 7.5% O2, balance in N2; hatched and
solid bars, respectively) before (control) and 1, 2, and 4 hours after
10 minutes of global cerebral ischemia. Values are mean±SEM
for 7 animals. *P<.05 compared with the lower level of
hypoxia.
). Cerebral arteriolar dilation to
hypoxia was not significantly reduced at 1, 2, or 4 hours after
ischemia (Table 1
; Fig 1
).
; Fig 2
).
Repeated application of adenosine resulted in reproducible
cerebral arteriolar dilation over time without altering baseline
diameters (Table 2
). As shown in Fig 2
, pial arteriolar dilation to
adenosine was unaffected by ischemia.
View this table:
[in a new window]
Table 2. Arteriolar Responses to Adenosine

View larger version (37K):
[in a new window]
Figure 2. Percent change from baseline pial arteriolar
diameter during topical application of adenosine
(105 and 104 mol/L) in the time control
group (hatched bars, n=6) and in the ischemia group (solid
bars, n=9). Second application was 1 hour after 10 minutes of global
ischemia. Values are mean±SEM. *P<.05 compared
with the lower dose of adenosine.
). In the two groups, before
application of the KATP antagonist, baseline
diameters were 104±2 and 101±3 µm, and diameters were 106±2
and 100±4 µm 5 minutes later, respectively, for the two
concentrations. Cerebral arteriolar dilation to adenosine was
reduced by approximately one half at either dose of glibenclamide
(Table 2
).
). However,
ischemia reduced cerebral arteriolar responses to hypercapnia
for up to 4 hours.
View this table:
[in a new window]
Table 3. Arteriolar Responses to Hypercapnia
![]()
Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Introduction
References
The major new finding is that ischemia does not alter
cerebral arteriolar dilation to arterial hypoxia
and to adenosine in piglets. Thus, despite a substantial
contribution of KATP to arteriolar dilation to
hypoxia and adenosine, normal responsiveness is intact.
In contrast to arterial hypoxia and
adenosine, cerebral arteriolar dilation to arterial
hypercapnia is reduced by ischemia. Thus, cerebrovascular
responses to arterial hypoxia and
arterial hypercapnia, two stimuli commonly used to elicit
cerebral arteriolar dilation as well as individual components of
asphyxia, are differentially sensitive to anoxic stress.
![]()
Selected Abbreviations and Acronyms
aCSF
=
artificial cerebrospinal fluid
CGRP
=
calcitonin generelated peptide
KATP
=
ATP-sensitive K+ channels
![]()
Acknowledgments
This study was supported by grants HL-30260, HL-46558, and
HL-50587 from the National Institutes of Health and a grant from the
Hungarian Ministry of Education (FKFP 0713/1997).
![]()
References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Introduction
References
Editorial Comment
![]()
Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Introduction
References
Cerebral ischemia can activate any of a multitude
of complex mechanisms, depending on the duration, location, and
intensity of the insult.1 Some of these mechanisms, such
as the release of nitric oxide2 3 and excitatory amino
acids,4 contribute directly to the immediate neuronal
death characteristic of cerebral ischemic damage. Other
mechanisms target the cerebral vasculature and alter its reactivity,
resulting in both immediate and long-term consequences for
postischemic recovery. Among the cerebrovascular responses
long known to be particularly vulnerable to ischemia is the
ability of the cerebral circulation to autoregulate its blood
flow.5 In addition, cerebral ischemia can
attenuate hypercapnic reactivity, although this effect appears more
variably6 7 than loss of autoregulation. Reactivity to
hypoxia can also be attenuated by ischemia, but this
response is probably the least vulnerable of all cerebrovascular
responses,8 due perhaps in large part to the redundancy of
mechanisms that mediate hypoxic cerebral vasodilatation.9
Thus overall, ischemia produces a graded and selective loss of
essential cerebrovascular responses in proportion to the severity and
nature of the insult.
25 mm Hg) and therefore may not
accurately predict responses to hypoxia of greater duration or
intensity. Typically, more severe hypoxia produces greater
decreases in the cellular ATP-to-ADP ratio and therefore may more
vigorously activate ATP-sensitive potassium channels and
heighten any apparent effects of channel dysfunction. Finally, the
effects of ischemia are dramatically different in mature and
immature brains,15 16 17 as is the functional capacity of
cerebrovascular ATP-sensitive potassium channels,18 and
thus the results may not exactly predict the effects of
ischemia on hypoxic cerebral vasodilatation in the adult.
Nonetheless, the study by Bari et al advances the important concept
that in neonates, as previously shown in adults,8
cerebrovascular responses to hypoxia are more robust than are
responses to changes in arterial carbon dioxide tension.
This strongly implies that cerebrovascular reactivity to
hypoxia may be expected to survive a moderate ischemic
insult but loss of this reactivity is a reliable indicator of poor
outcome after a major cerebrovascular ischemic insult,
regardless of age.
![]()
Selected Abbreviations and Acronyms
aCSF
=
artificial cerebrospinal fluid
CGRP
=
calcitonin generelated peptide
KATP
=
ATP-sensitive K+ channels
![]()
References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Introduction
References
This article has been cited by other articles:
![]() |
E. M. Sanhueza, R. A. Riquelme, E. A. Herrera, D. A. Giussani, C. E. Blanco, M. A. Hanson, and A. J. Llanos Vasodilator tone in the llama fetus: the role of nitric oxide during normoxemia and hypoxemia Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R776 - R783. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Armstead Role of Nociceptin/Orphanin FQ in the Physiologic and Pathologic Control of the Cerebral Circulation Experimental Biology and Medicine, December 1, 2002; 227(11): 957 - 968. [Abstract] [Full Text] |
||||
![]() |
F. Domoki, R. Veltkamp, N. Thrikawala, G. Robins, F. Bari, T. M. Louis, and D. W. Busija Ischemia-reperfusion rapidly increases COX-2 expression in piglet cerebral arteries Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1207 - H1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Marrelli, T. D. Johnson, A. Khorovets, W. F. Childres, R. M. Bryan Jr, and D. W. Busija Altered Function of Inward Rectifier Potassium Channels in Cerebrovascular Smooth Muscle After Ischemia/Reperfusion • Editorial Comment Stroke, July 1, 1998; 29(7): 1469 - 1474. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |